Together, these observations suggest that the tumor cells with high A3C expression also require high expression levels of DDX5 in R-loop components to mitigate the cytotoxic effect of gemcitabine against R-loop accumulation, substantiating the relevance of DNA deaminase-RNA helicase cascade to gemcitabine resistance. Here, DDX5 is linked to neoplasm.